Hybio Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	139.18	94.87	344.01	106.26	138.92	451.65
Trading Asset Securities	1.25	1.11	-	160.57	477.68	-
Cash & Short-Term Investments	140.42	95.97	344.01	266.83	616.6	451.65
Cash Growth	1.93%	-72.10%	28.92%	-56.73%	36.52%	-44.97%
Accounts Receivable	94.53	99.87	145.42	318.07	282.64	332.01
Other Receivables	7.01	11.15	22.44	11.88	54.39	24.08
Receivables	101.54	111.02	167.87	329.95	337.03	356.09
Inventory	288.16	238.63	152.59	189.96	157.14	186.76
Prepaid Expenses	-	10.29	2.56	0.19	-	-
Other Current Assets	34.97	7.14	16.61	25.39	44.31	52.53
Total Current Assets	565.09	463.05	683.64	812.32	1,155	1,047
Property, Plant & Equipment	1,710	1,674	1,734	1,942	1,993	1,980
Long-Term Investments	6.41	89.11	105.85	131.11	139.74	301.88
Goodwill	-	-	-	-	0.19	-
Other Intangible Assets	273.42	293.41	222.5	265.05	263.56	317.36
Long-Term Deferred Tax Assets	43.72	43.76	39.55	38.01	34.07	37.73
Long-Term Deferred Charges	169.39	175.99	217.81	250.41	228.02	282.37
Other Long-Term Assets	402.12	268.53	273.73	172.5	93.2	53.59
Total Assets	3,171	3,008	3,277	3,611	3,906	4,020
Accounts Payable	236.46	218.26	108.5	129.05	90.73	125.48
Accrued Expenses	13.64	78.5	100.92	49.16	72.78	36.31
Short-Term Debt	766.41	638.99	634.21	320.92	338.23	583.16
Current Portion of Long-Term Debt	290.37	293.53	453.18	456.11	63.05	218.66
Current Portion of Leases	-	0.82	0.21	2.88	11.06	-
Current Income Taxes Payable	9.51	6.72	2.84	-	0.32	2.01
Current Unearned Revenue	85.67	130.55	55.33	62.69	48.79	74.21
Other Current Liabilities	114.62	57.17	68.26	127.14	118.86	57.18
Total Current Liabilities	1,517	1,425	1,423	1,148	743.82	1,097
Long-Term Debt	873.07	864.58	942.05	1,026	1,377	1,148
Long-Term Unearned Revenue	96.9	106.91	101.19	118.62	124.73	90.55
Long-Term Deferred Tax Liabilities	11.63	8.84	5.01	4.2	0.81	1.1
Other Long-Term Liabilities	6.29	6.29	22.29	17.06	12.3	6.26
Total Liabilities	2,505	2,411	2,494	2,314	2,258	2,342
Common Stock	883.24	883.24	883.24	916.93	916.93	916.93
Additional Paid-In Capital	1,448	1,448	1,463	1,748	1,700	1,777
Retained Earnings	-1,722	-1,794	-1,627	-1,113	-740	-770.81
Treasury Stock	-	-	-	-318.66	-318.66	-318.66
Comprehensive Income & Other	40.38	41.22	39.27	37.5	26.51	33.02
Total Common Equity	649.15	578.63	758.8	1,271	1,585	1,638
Minority Interest	16.93	18.42	24.41	26.3	63.31	40.34
Shareholders' Equity	666.08	597.05	783.21	1,297	1,648	1,678
Total Liabilities & Equity	3,171	3,008	3,277	3,611	3,906	4,020
Total Debt	1,930	1,798	2,030	1,806	1,789	1,949
Net Cash (Debt)	-1,789	-1,702	-1,686	-1,540	-1,173	-1,498
Net Cash Per Share	-2.02	-1.96	-1.90	-1.74	-1.14	-1.62
Filing Date Shares Outstanding	883.24	883.24	883.24	883.24	883.24	883.24
Total Common Shares Outstanding	883.24	883.24	883.24	883.24	883.24	883.24
Working Capital	-951.59	-961.51	-739.8	-335.63	411.26	-49.98
Book Value Per Share	0.73	0.66	0.86	1.44	1.79	1.85
Tangible Book Value	375.73	285.21	536.31	1,006	1,321	1,320
Tangible Book Value Per Share	0.43	0.32	0.61	1.14	1.50	1.49
Buildings	-	1,577	1,560	1,537	1,058	609.4
Machinery	-	896.3	832.92	774.95	769.85	648.13
Construction In Progress	-	37.11	67.32	153.99	699.74	1,188

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.